Eyebot raised $20M in Series A funding to expand its 90-second vision exam kiosks which generate prescriptions reviewed and verified by licensed doctors. The Boston-based startup has run 45,000 free tests since its original seed funding and is on track to exceed 500,000 annually. Eyebot kiosks are currently deployed in malls, universities, pharmacies, and airports that offer free exams while charging a fee for prescriptions and leasing units to retailers. The round was led by General Catalyst.
- Company
- Eyebot eyebot.co
- Round
- Series A
- Amount
- $20M
- Source
- techcrunch.com
- In the newsletter
- No. 196, Electrify Everything